An Update on Salsalate, an Aspirin-Like Drug That Lowers Blood Glucose and Fights Inflammation

If salsalate is shown to be effective against high BG levels and inflammation, it could become a cheap and safe diabetes drug. Doctors have used salsalate for years, with no ill effects, to treat arthritic inflammation.

Jan 27, 2009

We first reported on salsalate, an aspirin-like drug discovered in the nineteenth century, last October. At that time, researchers at the Joslin Diabetes Center in Boston discovered that it appears to reduce inflammation and lower blood glucose in people with type 2 diabetes.

The encouraging findings of that earlier study have led to the initiation of a full-blown study, "TINSAL-T2D" (Targeting Inflammation with Salsalate in Type 2 Diabetes), for which Joslin researchers are now recruiting participants nationwide. The one-year study will require the participation of 560 adults from the ages of 18 to 75. They must not be using insulin (although one or two oral medications are permissible) and must have poor blood sugar control. 

Participants will receive either salsalate or a placebo. Although salsalate is an aspirin-type medicine, it does not cause the stomach upset that aspirin does in many users. This means that TINSAL-T2D participants will have a hard time telling whether they are receiving the actual drug-a boon to researchers concerned about keeping the study results as objective as possible. 

The hope is that if salsalate  is shown to be effective against high BG levels and inflammation,  it will become a cheap and safe addition to the growing pharmacopeia of anti-diabetes drugs. Doctors have used salsalate for years, with no ill effects, to treat arthritic inflammation.

Because inflammation increases the risk of coronary heart disease, the Joslin researchers will also be looking to see if treating type 2s with salsalate reduces the occurrence of heart disease among them.

(To learn more about the study, the link at www.tinsalt2d.org provides a list of study sites.  For more information, you can reach the study leader, Allison B. Goldfine, MD, via e-mail at Allison.Goldfine@joslin.harvard.edu.)

Click Here To View Or Post Comments

Categories: Blood Glucose, Blood Sugar, Diabetes, Diabetes, Insulin, Medications Research, Professional Issues, Type 2 Issues, Type 2 Medications


Diabetes Health Professional
Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (2)

You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 2 comments - Jan 27, 2009

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.